PDS Biotechnology Statistics
Total Valuation
PDSB has a market cap or net worth of $64.46 million. The enterprise value is $44.60 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, before market open.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PDSB has 45.40 million shares outstanding. The number of shares has increased by 18.19% in one year.
Current Share Class | 45.40M |
Shares Outstanding | 45.40M |
Shares Change (YoY) | +18.19% |
Shares Change (QoQ) | +8.09% |
Owned by Insiders (%) | 3.11% |
Owned by Institutions (%) | 8.77% |
Float | 39.57M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.84 |
P/TBV Ratio | 3.39 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 1.15 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.98 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | -43.24% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.48M |
Employee Count | 24 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -2.04M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.43% in the last 52 weeks. The beta is 1.39, so PDSB's price volatility has been higher than the market average.
Beta (5Y) | 1.39 |
52-Week Price Change | -59.43% |
50-Day Moving Average | 1.21 |
200-Day Moving Average | 2.15 |
Relative Strength Index (RSI) | 61.53 |
Average Volume (20 Days) | 238,711 |
Short Selling Information
The latest short interest is 2.97 million, so 6.54% of the outstanding shares have been sold short.
Short Interest | 2.97M |
Short Previous Month | 3.00M |
Short % of Shares Out | 6.54% |
Short % of Float | 7.51% |
Short Ratio (days to cover) | 11.14 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -35.33M |
Pretax Income | -45.29M |
Net Income | -35.50M |
EBITDA | -35.27M |
EBIT | -35.33M |
Earnings Per Share (EPS) | -$0.94 |
Full Income Statement Balance Sheet
The company has $41.69 million in cash and $21.83 million in debt, giving a net cash position of $19.86 million or $0.44 per share.
Cash & Cash Equivalents | 41.69M |
Total Debt | 21.83M |
Net Cash | 19.86M |
Net Cash Per Share | $0.44 |
Equity (Book Value) | 19.00M |
Book Value Per Share | 0.50 |
Working Capital | n/a |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PDSB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -18.19% |
Shareholder Yield | -18.19% |
Earnings Yield | -55.06% |
FCF Yield | n/a |
Analyst Forecast
The average price target for PDSB is $10.00, which is 604.23% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $10.00 |
Price Target Difference | 604.23% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on March 18, 2019. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Mar 18, 2019 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |